• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在未进行超声扫描和抗凝的情况下拔除带隧道中心静脉血液透析导管后致命和非致命性肺血栓栓塞的发生率

Incidence of fatal and non-fatal pulmonary thromboembolism after removal of tunnelled central venous haemodialysis catheters without ultrasound scan and anticoagulation.

作者信息

Macpherson Ciara, Stoumpos Sokratis, Geddes Colin C

机构信息

Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.

出版信息

J Vasc Access. 2025 Jul;26(4):1224-1228. doi: 10.1177/11297298241264855. Epub 2024 Aug 3.

DOI:10.1177/11297298241264855
PMID:39097786
Abstract

BACKGROUND

Catheter related thrombosis is a common complication of tunnelled central venous catheter (TCVC) usage. There are concerns that TCVC removal could dislodge a thrombus to cause pulmonary thromboembolism (PE). The incidence of PE following TCVC removal is unclear and so the aim of this study was to investigate the incidence of PE and whether it is high enough to warrant screening with ultrasound with a view to systemic anticoagulation prior to TCVC removal.

METHODS

1102 consecutive TCVC removals without ultrasound and systemic anticoagulation were included in this retrospective study. Data were extracted from electronic health records. Measures to identify PE events included: deaths, computed tomography pulmonary angiogram (CT-PA), isotope lung perfusion scans and D-dimers blood tests within 7 days of removal.

RESULTS

Of the 1102 TCVC removals, the mean age of patients was 56.9 years and 57.3% were male. The primary renal diagnosis for 24.5% of patients was diabetic nephropathy. There were seven deaths following removal, none of which had PE as a contributing cause on review of their clinical history and death certificates. Five CT-PAs and one isotope lung perfusion scan were carried out in the 7 days after TCVC removal and none had a positive finding of PE. Three patient had D-dimers measured in blood within 7 days and none of these patients were subsequently diagnosed with PE.

CONCLUSIONS

There was no evidence of fatal or non-fatal PE's occurring in the 7 days following TCVC removal. This would support the practice of removing TCVCs without the need for ultrasound screening and without a period of systemic anticoagulation.

摘要

背景

导管相关血栓形成是隧道式中心静脉导管(TCVC)使用过程中的常见并发症。有人担心拔除TCVC可能会使血栓脱落,从而导致肺血栓栓塞症(PE)。拔除TCVC后发生PE的发生率尚不清楚,因此本研究的目的是调查PE的发生率,以及该发生率是否高到足以保证在拔除TCVC前进行超声筛查并考虑全身抗凝。

方法

本回顾性研究纳入了1102例连续拔除的未进行超声检查和全身抗凝的TCVC。数据从电子健康记录中提取。识别PE事件的措施包括:拔除后7天内的死亡情况、计算机断层扫描肺动脉造影(CT-PA)、同位素肺灌注扫描和D-二聚体血液检测。

结果

在1102例TCVC拔除病例中,患者的平均年龄为56.9岁,男性占57.3%。24.5%患者的主要肾脏诊断为糖尿病肾病。拔除后有7例死亡,经审查其临床病史和死亡证明,均无PE作为促成死因。在拔除TCVC后的7天内进行了5次CT-PA和1次同位素肺灌注扫描,均未发现PE阳性结果。3例患者在7天内进行了血液D-二聚体检测,这些患者随后均未被诊断为PE。

结论

没有证据表明在拔除TCVC后的7天内发生了致命或非致命性PE。这将支持在无需超声筛查和全身抗凝期的情况下拔除TCVC的做法。

相似文献

1
Incidence of fatal and non-fatal pulmonary thromboembolism after removal of tunnelled central venous haemodialysis catheters without ultrasound scan and anticoagulation.在未进行超声扫描和抗凝的情况下拔除带隧道中心静脉血液透析导管后致命和非致命性肺血栓栓塞的发生率
J Vasc Access. 2025 Jul;26(4):1224-1228. doi: 10.1177/11297298241264855. Epub 2024 Aug 3.
2
Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.预防带隧道式中心静脉导管的儿科癌症患者发生静脉血栓栓塞事件的全身治疗。
Cochrane Database Syst Rev. 2013 Sep 11(9):CD009160. doi: 10.1002/14651858.CD009160.pub2.
3
Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients.用于预防肿瘤患者早期中心静脉导管革兰氏阳性菌感染的预防性抗生素。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003295. doi: 10.1002/14651858.CD003295.pub2.
4
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.经导管治疗高危(大块)和中危(次大块)急性肺栓塞。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
5
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症(VTE)患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
6
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
7
Dressings and securement devices for central venous catheters (CVC).中心静脉导管(CVC)的敷料和固定装置。
Cochrane Database Syst Rev. 2015 Sep 10;2015(9):CD010367. doi: 10.1002/14651858.CD010367.pub2.
8
Are Patients With Morbid Obesity at Increased Risk of Pulmonary Embolism or Proximal Deep Vein Thrombosis After Lower Limb Arthroplasty? A Large-database Study.肥胖症患者下肢关节置换术后发生肺栓塞或近端下肢深静脉血栓的风险是否增加?一项大数据库研究。
Clin Orthop Relat Res. 2024 Jan 1;482(1):115-124. doi: 10.1097/CORR.0000000000002742. Epub 2023 Jul 4.
9
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
10
Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters.用于预防新生儿中心静脉导管相关感染的抗菌敷料。
Cochrane Database Syst Rev. 2016 Mar 23;3(3):CD011082. doi: 10.1002/14651858.CD011082.pub2.